SNTI - Senti Biosciences Inc.
3.21
-0.130 -4.050%
Share volume: 20,000
Last Updated: 03-13-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.34
-0.13
-0.04%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-09-2023 | 08-11-2023 | 11-14-2023 | 03-21-2024 | 05-09-2024 | 08-13-2024 | 11-14-2024 | |
| Cash flow financing | -35.000 K | 281.000 K | -23.000 K | 556.000 K | 0.000 | 0.000 | 2.440 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 2.430 M | |
| Cash flow | -16.304 M | -13.675 M | -15.379 M | -7.037 M | -11.682 M | 0.000 | -5.366 M | |
| Net income | -18.722 M | -18.697 M | -14.923 M | -18.716 M | -12.111 M | -11.203 M | -28.866 M | |
| Depreciation | 929.000 K | 1.211 M | 1.815 M | 1.474 M | 1.461 M | 971.000 K | 946.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 791.000 K | 567.000 K | 18.620 M | 17.704 M | 17.923 M | 0.000 | 0.000 | |
| Investing Cashflow | -9.497 M | 18.331 M | 21.142 M | 101.000 K | -15.000 K | 0.000 | 60.000 K | |
| Net Borrowings | -41.630 M | -24.685 M | -23.074 M | -15.830 M | -1.020 M | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -6.507 M | -3.669 M | -1.858 M | -4.000 K | -15.000 K | 0.000 | 0.000 | |
| Cash Change | 76.106 M | 59.635 M | 39.430 M | 35.926 M | 23.723 M | -8.345 M | -5.366 M |